Controlled release systems for DNA delivery.
暂无分享,去创建一个
[1] D. Putnam,et al. PLGA microspheres containing plasmid DNA: preservation of supercoiled DNA via cryopreparation and carbohydrate stabilization. , 1999, Journal of pharmaceutical sciences.
[2] M. L. La Rotonda,et al. Poly(lactide-co-glycolide) microspheres for the controlled release of oligonucleotide/polyethylenimine complexes. , 2002, Journal of pharmaceutical sciences.
[3] Kristi S. Anseth,et al. Gene Delivery in Tissue Engineering: A Photopolymer Platform to Coencapsulate Cells and Plasmid DNA , 2003, Pharmaceutical Research.
[4] S. Andreadis,et al. High Efficiencies of Gene Transfer with Immobilized Recombinant Retrovirus: Kinetics and Optimization , 2001, Biotechnology progress.
[5] R. Barr,et al. Electromobility of plasmid DNA in tumor tissues during electric field-mediated gene delivery , 2002, Gene Therapy.
[6] M. Spector,et al. Gene delivery to cartilage defects using coagulated bone marrow aspirate , 2004, Gene Therapy.
[7] P. Hornsby,et al. Transfection by Polyethyleneimine-Coated Microspheres , 2001, Journal of drug targeting.
[8] H. HogenEsch,et al. Encapsulation of recombinant adenovirus into alginate microspheres circumvents vector-specific immune response , 2002, Gene Therapy.
[9] Jayanth Panyam,et al. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. , 2003, Advanced drug delivery reviews.
[10] M. Barry,et al. Metabolic biotinylation of recombinant proteins in mammalian cells and in mice. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.
[11] C. Plank,et al. Nonviral vector loaded collagen sponges for sustained gene delivery in vitro and in vivo , 2002, The journal of gene medicine.
[12] M. Barry,et al. Metabolic biotinylation of secreted and cell surface proteins from mammalian cells. , 2001, Biochemical and biophysical research communications.
[13] Y. Tabata,et al. Local delivery of matrix metalloproteinase gene prevents the onset of renal sclerosis in streptozotocin-induced diabetic mice. , 2003, Tissue engineering.
[14] Weiliam Chen,et al. Characterization of DNA-hyaluronan matrix for sustained gene transfer. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[15] Y. Capan,et al. Influence of formulation parameters on the characteristics of poly(D, L-lactide-co-glycolide) microspheres containing poly(L-lysine) complexed plasmid DNA. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[16] W. Anderson,et al. Human gene therapy. , 1992, Science.
[17] Cato T Laurencin,et al. Development of a calcium phosphate co-precipitate/poly(lactide-co-glycolide) DNA delivery system: release kinetics and cellular transfection studies. , 2004, Biomaterials.
[18] N. Weiner,et al. Application of membrane-based dendrimer/DNA complexes for solid phase transfection in vitro and in vivo. , 2000, Biomaterials.
[19] C. Dinney,et al. Repeated intravesical instillations of an adenoviral vector in patients with locally advanced bladder cancer: a phase I study of p53 gene therapy. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] N. Rainov,et al. Gene Therapy for Human Malignant Brain Tumors , 2003, Cancer journal.
[21] Jeffrey Bonadio,et al. Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration , 1999, Nature Medicine.
[22] S. Diamond,et al. Endovascular Microcoil Gene Delivery Using Immobilized Anti-adenovirus Antibody for Vector Tethering , 2002, Stroke.
[23] Y. Capan,et al. Stability of poly(L-lysine)-complexed plasmid DNA during mechanical stress and DNase I treatment. , 1999, Pharmaceutical development and technology.
[24] H. Cavanagh,et al. Cell contact dependent extended release of adenovirus by microparticles in vitro. , 2001, Journal of virological methods.
[25] Helmuth van Es,et al. Arrayed adenoviral expression libraries for functional screening , 2002, Nature Biotechnology.
[26] B. Olsen,et al. Delivery of plasmid DNA to articular chondrocytes via novel collagen-glycosaminoglycan matrices. , 2002, Human gene therapy.
[27] Davidson,et al. Extended release of adenovirus from polymer microspheres: potential use in gene therapy for brain tumors. , 1997, Advanced drug delivery reviews.
[28] C. Bertozzi,et al. Engineering Novel Cell Surface Receptors for Virus-mediated Gene Transfer* , 1999, The Journal of Biological Chemistry.
[29] Weiliam Chen,et al. Hyaluronan microspheres for sustained gene delivery and site-specific targeting. , 2004, Biomaterials.
[30] K. Leong,et al. Gene transfer by DNA-gelatin nanospheres. , 1999, Archives of biochemistry and biophysics.
[31] H. Roehl,et al. Phase 1 trial of FVIII gene transfer for severe hemophilia A using a retroviral construct administered by peripheral intravenous infusion. , 2003, Blood.
[32] D. Lauffenburger,et al. Quantitative analysis of synthetic gene delivery vector design properties. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.
[33] G F Pierce,et al. Collagen-embedded platelet-derived growth factor DNA plasmid promotes wound healing in a dermal ulcer model. , 2000, The Journal of surgical research.
[34] M. Herlyn,et al. Matrix immobilization enhances the tissue repair activity of growth factor gene therapy vectors. , 2001, Human gene therapy.
[35] R. Levy,et al. Gene delivery from a DNA controlled-release stent in porcine coronary arteries , 2000, Nature Biotechnology.
[36] K. Yip,et al. Controlled release of plasmid DNA , 1997 .
[37] I. Alferiev,et al. Localized gene delivery using antibody tethered adenovirus from polyurethane heart valve cusps and intra-aortic implants , 2004, Gene therapy.
[38] W. Mark Saltzman,et al. Enhancement of transfection by physical concentration of DNA at the cell surface , 2000, Nature Biotechnology.
[39] J. Engh,et al. In vivo endochondral bone formation using a bone morphogenetic protein 2 adenoviral vector. , 1999, Human gene therapy.
[40] Jon Dobson,et al. Improved method of recombinant AAV2 delivery for systemic targeted gene therapy. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.
[41] F. Szoka,et al. Robust and prolonged gene expression from injectable polymeric implants , 2002, Gene Therapy.
[42] Scott D. Putney,et al. Improving protein therapeutics with sustained-release formulations , 1998, Nature Biotechnology.
[43] B. Davidson,et al. Poly-L-lysine improves gene transfer with adenovirus formulated in PLGA microspheres , 1999, Gene Therapy.
[44] Hassan Adwan,et al. Delivery and expression of pDNA embedded in collagen matrices. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[45] David M Sabatini,et al. Cell-biological applications of transfected-cell microarrays. , 2002, Trends in cell biology.
[46] H. Herweijer,et al. Progress and prospects: naked DNA gene transfer and therapy , 2003, Gene Therapy.
[47] T. Ochiya,et al. Biomaterials for gene delivery: atelocollagen-mediated controlled release of molecular medicines. , 2001, Current gene therapy.
[48] J. Hubbell,et al. Development of growth factor fusion proteins for cell‐triggered drug delivery , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[49] W. Saltzman,et al. Gene expression and mucosal immune responses after vaginal DNA immunization in mice using a controlled delivery matrix. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[50] M. Herlyn,et al. FGF2-Targeted adenovirus encoding platelet-derived growth factor-B enhances de novo tissue formation. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.
[51] D. Kniss,et al. Three-dimensional cell-scaffold constructs promote efficient gene transfection: implications for cell-based gene therapy. , 2001, Tissue engineering.
[52] J. Tartaglia,et al. Viral vector delivery in solid-state vehicles: gene expression in a murine prostate cancer model. , 2000, Journal of the National Cancer Institute.
[53] R. Proctor. Fibronectin: a brief overview of its structure, function, and physiology. , 1987, Reviews of infectious diseases.
[54] W. Mark Saltzman,et al. Building drug delivery into tissue engineering design , 2002, Nature Reviews Drug Discovery.
[55] K. Leong,et al. Coacervate microspheres as carriers of recombinant adenoviruses , 1999, Cancer Gene Therapy.
[56] P. Hornsby,et al. Transfection of Cells Mediated by Biodegradable Polymer Materials with Surface‐Bound Polyethyleneimine , 2000, Biotechnology progress.
[57] S. Goldstein,et al. Gene transfection using biodegradable nanospheres: results in tissue culture and a rat osteotomy model , 1999 .
[58] Leaf Huang,et al. Nonviral vectors in the new millennium: delivery barriers in gene transfer. , 2001, Human gene therapy.
[59] J. L. Raina,et al. Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus. , 1992, Virology.
[60] T. Segura,et al. Substrate-mediated DNA delivery: role of the cationic polymer structure and extent of modification. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[61] T. Niidome,et al. Gene Therapy Progress and Prospects: Nonviral vectors , 2002, Gene Therapy.
[62] L. Barrett,et al. Sustained Effects of Gene-Activated Matrices after CNS Injury , 2001, Molecular and Cellular Neuroscience.
[63] P. Weston,et al. Transfection of HEK Cells via DNA-loaded PLGA and P(FASA) Nanospheres , 2002, Journal of drug targeting.
[64] Tatiana Segura,et al. Materials for Non-Viral Gene Delivery , 2001 .
[65] Donald E. Chickering,et al. Biologically erodable microspheres as potential oral drug delivery systems , 1997, Nature.
[66] Lonnie D Shea,et al. Drug-releasing scaffolds fabricated from drug-loaded microspheres. , 2002, Journal of biomedical materials research.
[67] M. Benet,et al. Stability of PEI-DNA and DOTAP-DNA complexes: effect of alkaline pH, heparin and serum. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[68] F. Szoka,et al. Effect of serum components on the physico-chemical properties of cationic lipid/oligonucleotide complexes and on their interactions with cells. , 1998, Biochimica et biophysica acta.
[69] P. Robbins,et al. Adenovirus-mediated direct gene therapy with bone morphogenetic protein-2 produces bone. , 1999, Bone.
[70] K. Leong,et al. DNA-polycation nanospheres as non-viral gene delivery vehicles. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[71] O. Ludkovski,et al. Stabilized plasmid-lipid particles for systemic gene therapy. , 2000, Gene therapy.
[72] L. Chandler,et al. Delivery of FGF genes to wound repair cells enhances arteriogenesis and myogenesis in skeletal muscle. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.
[73] David J Mooney,et al. Fabrication and in vitro testing of polymeric delivery system for condensed DNA. , 2003, Journal of biomedical materials research. Part A.
[74] D. McDonald,et al. Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells , 2000, Gene Therapy.
[75] Daniel W Pack,et al. Microspheres for controlled release drug delivery , 2004, Expert opinion on biological therapy.
[76] T. Ochiya,et al. New delivery system for plasmid DNA in vivo using atelocollagen as a carrier material: the Minipellet , 1999, Nature Medicine.
[77] Fred D. Ledley,et al. Pharmaceutical Approach to Somatic Gene Therapy , 1996, Pharmaceutical Research.
[78] D. Kerr,et al. Taking Gene Therapy into the Clinic , 2003, Journal of Biomedicine and Biotechnology.
[79] B. Davidson,et al. Poly (lactic-glycolic) acid copolymer encapsulation of recombinant adenovirus reduces immunogenicity in vivo , 1998, Gene Therapy.
[80] T. Schiestel,et al. A nonviral DNA delivery system based on surface modified silica-nanoparticles can efficiently transfect cells in vitro. , 2000, Bioconjugate chemistry.
[81] D. Sabatini,et al. Microarrays of cells expressing defined cDNAs , 2001, Nature.
[82] David Kerr,et al. Clinical development of gene therapy for colorectal cancer , 2003, Nature Reviews Cancer.
[83] W. Norde,et al. Why proteins prefer interfaces. , 1991, Journal of biomaterials science. Polymer edition.
[84] R. Langer,et al. A theoretical model of erosion and macromolecular drug release from biodegrading microspheres. , 1997, Journal of pharmaceutical sciences.
[85] Jayanth Panyam,et al. Rapid endo‐lysosomal escape of poly(DL‐lactide‐coglycolide) nanoparticles: implications for drug and gene delivery , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[86] Biodegradable microparticles for the controlled delivery of oligonucleotides. , 2002, International journal of pharmaceutics.
[87] R. Levy,et al. Gene delivery to pig coronary arteries from stents carrying antibody-tethered adenovirus. , 2002, Human gene therapy.
[88] E. Canning,et al. A triploblast origin for Myxozoa? , 1998, Nature.
[89] R. Levy,et al. Localized adenovirus gene delivery using antiviral IgG complexation , 2001, Gene Therapy.
[90] R. Levy,et al. Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles , 2000, Gene Therapy.
[91] Jae-Hyung Jang,et al. Controllable delivery of non-viral DNA from porous scaffolds. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[92] Tatiana Segura,et al. Surface-tethered DNA complexes for enhanced gene delivery. , 2002, Bioconjugate chemistry.
[93] Y. Tabata,et al. Biodegradable gelatin hydrogel potentiates the angiogenic effect of fibroblast growth factor 4 plasmid in rabbit hindlimb ischemia. , 2003, Journal of the American College of Cardiology.
[94] S. Miyatake,et al. Osteoinduction by bone morphogenetic protein-2 via adenoviral vector under transient immunosuppression. , 2000, Biochemical and biophysical research communications.
[95] M. Pandori,et al. Adenovirus-microbead conjugates possess enhanced infectivity: a new strategy for localized gene delivery. , 2002, Virology.
[96] David J. Mooney,et al. DNA delivery from polymer matrices for tissue engineering , 1999, Nature Biotechnology.
[97] B. Palsson,et al. The physico-chemical factors that govern retrovirus-mediated gene transfer. , 1997, Experimental hematology.
[98] S. Mohapatra. Mucosal gene expression vaccine: a novel vaccine strategy for respiratory syncytial virus , 2003, The Pediatric infectious disease journal.
[99] S. Goldstein,et al. Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[100] T Ochiya,et al. Atelocollagen-based gene transfer in cells allows high-throughput screening of gene functions. , 2001, Biochemical and biophysical research communications.
[101] D. Mooney,et al. Controlled delivery of inductive proteins, plasmid DNA and cells from tissue engineering matrices. , 1999, Journal of periodontal research.